Sai Abhishek

Sai Abhishek is an experienced professional in biotechnology venture capital and business development, currently working at Enavate Sciences since 2024, focusing on supporting therapeutic companies with innovative medicines. Prior to this role, Sai held positions at Code Biotherapeutics, New Enterprise Associates, and Credit Suisse, where responsibilities included portfolio strategy, healthcare venture capital, and investment banking in strategic transactions. Early career experiences included roles in biotechnology venture capital at ATP and research positions at Penn Medicine, Cornell University, and the University of Pennsylvania, contributing to significant projects in genetic research and chemotherapy optimization. Sai holds a Bachelor of Science degree from The Wharton School, with concentrations in Finance, Statistics, and Biology.